ACADIA PHARMACEUTICALS INC. (ACAD) Revenue 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.1BFY2025 · since FY2016: $17.3M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +11.9% |
| FY2024 | $957.8M | +31.8% |
| FY2023 | $726.4M | +40.4% |
| FY2022 | $517.2M | +6.8% |
| FY2021 | $484.1M | +9.6% |
| FY2020 | $441.8M | +30.3% |
| FY2019 | $339.1M | +51.5% |
| FY2018 | $223.8M | +79.2% |
| FY2017 | $124.9M | +620.7% |
| FY2016 | $17.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice